Best Augmentation Cystoplasty Doctors in Teaneck, NJ

We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Anton George Kelly, MD is an Assistant Professor of Surgery in the division of Trauma, Burns, Critical and Acute Care at Weill Cornell Medical College and Assistant Attending Surgeon at New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Kelly specializes in Surgical Critical Care, Acute Care Surgery and Trauma with a focus on Traumatology and Burn management.Prior to his arrival, Dr. Kelly completed his residency in general surgery at Easton Hospital in Easton Pennsylvania followed by a dual fellowship in burn surgery and surgical critical care at New York-Presbyterian/Weill Cornell Medical Center and Westchester Medical Center respectively.Dr. Kelly is an active member of many prestigious medical and surgical societies, including the American College of Surgeons, Society of American Gastrointestinal and Endoscopic Surgeons, Society of Critical Care Medicine and the American Burn Association. He has also been published numerous peer-reviewed journal articles and abstracts.In addition, Dr. Kelly has been honored with the 2015 Physician of the Year Award from NewYork-Presbyterian/Weill Cornell Medical Center.

Urologic oncology is a multidisciplinary field that incorporates innovative surgical technology, systemic treatments such as chemotherapy as well as a focused research effort. As a Professor of Urology and the Clinical Director of Urologic Oncology I continually interact with colleagues in areas of medical oncology, radiation oncology, pathology among others in order to provide the most comprehensive and innovative care for our patients with prostate, bladder, kidney and testicular cancer. Advances in robotic technology along with scientific progress in our precision medicine program have allowed us to direct therapy in unprecedented ways. As a leader in this area I look forward to continued advances in this exciting and challenging field.

Joseph J. Del Pizzo, M.D. is the E. Darracott Vaughan Jr., Professor of Urology and the Director of the Advanced Minimally Invasive Kidney Donor Program for the Department of Urology at Weill Cornell Medicine. He joined the surgical staff at The New York Presbyterian Hospital in 2000 after serving as a clinical fellow in Laparoscopy and Minimally Invasive Urology. Prior to his fellowship, he completed his urology residency at the University of Maryland, one of the largest centers for urologic laparoscopy in the country, where he helped to establish some of the anatomical landmarks for performing laparoscopic live donor nephrectomy.At the New York Presbyterian Hospital, Dr. Del Pizzo has established one of the most active and effective centers for laparoscopic and robotic surgery in urology. He has vast experience in the laparoscopic and robotic treatment of kidney and adrenal tumors, kidney sparing surgery, and living kidney donation, having done over 2,000 cases including minimally invasive partial nephrectomy, radical nephrectomy, donor nephrectomy, nephroureterectomy, cryotherapy and adrenalectomy. He directs the laparoscopic donor nephrectomy program in conjunction with the Rogosin Institute of Transplantation, and performs approximately 150 of these procedures a year.Dr. Del Pizzo is an internationally recognized expert, speaker and author in the laparoscopic and robotic treatment of kidney tumors, as well as in minimally invasive living kidney donation. He currently serves on the faculty of the AUA Laparoscopy Course, where he instructs other urologists in learning laparoscopic surgery. In addition, he travels extensively around the world teaching other surgeons the techniques of laparoscopic and robotic kidney surgery.Dr. Del Pizzo's clinical expertise also includes the minimally invasive treatment of kidney stone disease. He has experience using both laser therapy and sound wave therapy to remove kidney stones without the need for surgical incisions.He is the recipient of numerous awards, including an Outstanding Achievement Award from The Society of Laparoendoscopic Surgeons. He is consistently named as one of The Best Doctors in America as well as a Top Doctor in the New York Metro Area. He works closely with surgical instrument companies and is actively involved in the development of new therapies for minimally invasive urologic surgery. He has authored many book chapters and published numerous manuscripts on topics related to his field of expertiseDr. Del Pizzo is currently licensed to practice medicine in the states of New York and Maryland._____________________________________________________________Testimonials"Dr.DelPizzois very professional and extremely easy to talk to. He even called me back to explain my lab results. I am very lucky to have him as my Urologist. I have recommended him to my friends and family." - Joe G. via Healthgrades on May 1,2020"I cannot say enough wonderful things about Dr. Del Pizzo and his entire staff. He is a warm, compassionate and charismatic individual and an amazing doctor. He explained everything in detail, answered all of my questions and completely put me at ease. He was quick to communicate my test results and ultimately resolved a chronic issue I have been dealing with for years. My experience with Dr. Del Pizzo was fortuitous to say the least and I am beyond grateful for his time, care and expertise." - JGallucci on October 3, 2017 via Healthgrades"After being diagnosed with kidney cancer , I reached out to his office and he offered to see me the same day. He was very courteous and knowledgeable, and eased my anxiety by handling the situation with the utmost professionalism. He performed the robotic surgery , cured my cancer and saved my kidney."- Anonmyous on September 22, 2017 via Vitals"Great doctor. He was my kidney donor's ( my son) surgeon. I also saw him to remove my stent. Wonderful, knowledgeable and caring doctor." - Anonymous on August 21, 2017 via RateMDs_____________________________________________________________

James McKiernan, MD, is the John K. Lattimer Professor of Urology, and CEO, of ColumbiaDoctors. He also is the interim dean of Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues. For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer.

Urologic oncology is a multidisciplinary field that incorporates innovative surgical technology, systemic treatments such as chemotherapy as well as a focused research effort. As a Professor of Urology and the Clinical Director of Urologic Oncology I continually interact with colleagues in areas of medical oncology, radiation oncology, pathology among others in order to provide the most comprehensive and innovative care for our patients with prostate, bladder, kidney and testicular cancer. Advances in robotic technology along with scientific progress in our precision medicine program have allowed us to direct therapy in unprecedented ways. As a leader in this area I look forward to continued advances in this exciting and challenging field.

Dr. Philippa Cheetham, MD is an Urology Specialist who practices in New York, NY. She has been practicing for 29 years. Dr. Philippa Cheetham, MD is affiliated with Mount Sinai Hospital.

Dr. Susan Marshall, MD is an Urology Specialist who practices in New York, NY. She is 43 years old and has been practicing for 17 years. Dr. Susan Marshall, MD is affiliated with Mount Sinai Morningside, Mount Sinai Hospital and Mount Sinai Queens.

Dr. Michael Palese, MD is a General Surgery Specialist who practices in New York, NY. He is 54 years old and has been practicing for 28 years. Dr. Michael Palese, MD is affiliated with Mount Sinai Hospital, Mount Sinai Brooklyn and Mount Sinai Morningside.

I understand the emotional burden that diagnosis of cancer can have on the patient and family members. I always would treat my patients as I would treatment my own family and friends. I understand quality of life is superbly important and would personalize treatment for each patient through extensive discussions and effective communication.